Increased risk of concurrent primary malignancies in patients diagnosed with a primary malignant epithelial ovarian tumor

Modern Pathology

Volumn 20, Issue 3, 2007, Pages 384-388

  Van Niekerk, Catharina C ^a   Vooijs, G Peter ^b   Bulten, Johan ^a   Van Dijck, Jos A A M ^a,c   Verbeek, Andre L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c Integraal Kankercentrum Oost   (Netherlands)

Author keywords

Clinical pathology and epidemiology; Ovarian cancer; Second malignancies

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 33847379479     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800752     Document Type: Article

References (15)

1. Weiss NS, Cook LS, Farrow DC. Ovarian cancer. In: Schottenfeld D, Fraumeni Jr JF (eds). Cancer Epidemiology and Prevention, 2nd edn. Oxford University Press: New York, 1996, pp 1040-1057.
2. Riman T, Dickman PW, Nilsson S, et al. Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. Am J Epidemiol 2002;156:363-373.
3. Hall HI, Jamison P, Weir HK. Second primary ovarian cancer among women diagnosed previously with cancer. Cancer Epidemiol Biom Prev 2001;10:995-999.
4. Sheu BC, Lin HH, Chen CK, et al. Synchronous primary carcinomas of the endometrium and ovary. Int J Gynecol Obstet 1995;51:141-146.
5. Hemminki K, Aaltonen L, Li X. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer 2003;97:2432-2439.
6. Travis LB, Curtis RE, Boice Jr JD, et al. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 1996;56:1564-1570.
7. Hartge P, Tucker MA, Shields JA, et al. Casecontrol study of female hormones and eye melanoma. Cancer Res 1989;49:4622-4625.
8. Netherlands Cancer Registry. http://www.ikcnet.nl/page.php?id=41(accessed 21 April 2006).
9. Eindhoven Cancer Registry: Comprehensive Cancer Centre South (IKZ); 1990-2000; 29 (personal communication).
10. Snedecor GW, Cochran WG. Sampling of attributes. In: Statistical Methods, 6th edn. The Iowa State University Press: Ames, Iowa, 1974, pp 3-31.
11. Buiatti E, Crocetti E, Acciai S, et al. Incidence of second primary cancers in three Italian population-based cancer registries. Eur J Cancer 1997;33:1829-1834.
12. Kehoe S, Powell JE. Prior, synchronous and secondary malignancies in women with ovarian cancer. Int J Gynecol Obstet 2001;73:265-267.
13. Bertone-Johnson ER. Epidemiology of ovarian cancer: a status report. Lancet 2005;365:101-102.
14. Vineis P. History of bias. In: Morabia A (ed). History of Epidemiologic Methods and Concepts. Birkhäuser Verlag: Basel, 2004, pp 327-336.
15. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonad, fallopian tube and broad ligament. In: Rosai J, Sobin LH (eds). Atlas of Tumor Pathology, 3rd series, Vol. 23. Armed Forces Institute of Pathology Press: Washington, 1998, pp 125-126.